It looks like you're new here. If you want to get involved, click one of these buttons!
The Securities and Exchange Commission is investigating the circumstances around Eastman Kodak’s announcement of a $765 million government loan to make drugs at its U.S. factories, according to people familiar with the matter.
The price spike briefly produced a potential windfall for company executives who owned stock-option grants, some of which were granted on July 27, the day before the loan was officially announced.
The SEC’s investigation is at an early stage and might not produce allegations of wrongdoing by the company or any individuals, the people familiar with the matter said. Among the areas being probed by regulators: how Kodak controlled disclosure of the loan, word of which began to emerge on July 27, causing Kodak’s stock price to rise 25% that day.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla
Comments
As I wrote a few days ago, let's put that "some" in perspective. KODK traded as high as $60 after the options were granted. The inflated price may fall all the way back to earth (it's down to $14.40) before these execs cash in by exercising their options.
No option here, Derf
Just add the mustache!
https://au.finance.yahoo.com/news/kodak-shares-slump-us-loan-195029583.html
WSJ article cited in report:
https://www.wsj.com/articles/u-s-agency-sidelines-planned-765-million-loan-to-kodak-amid-probes-11597018204